You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 49348-0303


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 49348-0303

Drug NameNDCPrice/Unit ($)UnitDate
SM ANTACID MAX STRENGTH SUSP 49348-0303-39 0.01170 ML 2025-03-19
SM ANTACID MAX STRENGTH SUSP 49348-0303-39 0.01161 ML 2025-02-19
SM ANTACID MAX STRENGTH SUSP 49348-0303-39 0.01142 ML 2025-01-22
SM ANTACID MAX STRENGTH SUSP 49348-0303-39 0.01160 ML 2024-12-18
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for NDC 49348-0303

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 49348-0303

Understanding National Drug Codes (NDCs)

Before diving into the market analysis and price projections for the drug with the NDC 49348-0303, it is crucial to understand what an NDC is. An NDC is a unique 11-digit, 3-segment numeric identifier assigned to each medication listed under Section 510 of the US Federal Food, Drug, and Cosmetic Act. This code helps in accurate billing, reimbursement, and management of drug costs[2][5].

Identifying the Drug

To analyze the market and price projections for the drug with NDC 49348-0303, we first need to identify the drug. However, the provided sources do not specify the drug associated with this NDC. Typically, this information can be found through databases such as the FDA's National Drug Code Directory or other pharmaceutical databases.

Market Segmentation and Pricing

The pharmaceutical market is highly segmented by price, with different segments including cash, insurer/PBM, Medicaid, and others. The pricing structure of prescription drugs is influenced by various factors such as demographic trends, technological advancements, legal and regulatory changes, and market competition[3].

Price Segments

  • Cash Segment: This segment involves direct payments by consumers. It is projected to decline if programs like Medicare drug benefits or state discount-only programs are implemented[3].
  • Insurer/PBM Segment: This segment involves payments made by insurance companies and pharmacy benefit managers. It tends to grow significantly with the implementation of programs like Medicare drug benefits[3].

Calculating Prices for Covered Outpatient Drugs

For drugs participating in the Medicaid Drug Rebate Program (MDRP), the pricing is governed by specific formulas. The 340B ceiling price, for example, is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure of the drug[5].

Billing and Reimbursement

Accurate billing and reimbursement depend on the correct use of NDCs, along with other billing information such as HCPCS/CPT codes, the amount of the drug administered, and the unit of measure. This ensures that the correct number of NDC units is billed, which directly affects the reimbursement amount[2].

Market Projections

Global and U.S. Market Trends

The global market for prescription drugs is expected to grow significantly. For instance, the global market for drug-device combinations is projected to grow from $129.4 billion in 2024 to $199.8 billion by 2029[3].

U.S. Prescription Drug Market

In the U.S., prescription drug sales have been growing steadily. Historical data shows that U.S. prescription drug sales grew from $277 billion in 2002 to $490 billion in 2008. Future projections indicate continued growth, though the rate can be influenced by regulatory changes and the implementation of new programs[3].

Specific Market Analysis for NDC 49348-0303

Without specific details about the drug associated with NDC 49348-0303, it is challenging to provide precise market analysis and price projections. However, here are some general steps that could be taken:

Determine the Drug Category

Identify whether the drug falls under a specific therapeutic category, such as chronic disease management or acute care. This helps in understanding the market demand and competition.

Analyze Historical Sales Data

Review historical sales data for the drug to identify trends and growth patterns. This data can be obtained from market research reports, pharmaceutical company financial statements, or industry databases.

Assess Market Drivers and Constraints

Evaluate the factors driving the market for this drug, such as demographic changes, technological advancements, and regulatory environments. Also, consider any constraints that might affect its pricing and sales.

Forecast Future Sales

Using historical data and market analysis, forecast future sales for the drug. This can be done using various statistical models and market research methodologies.

Example of Price Calculation

If we knew the drug associated with NDC 49348-0303 and its pricing structure, we could calculate the 340B ceiling price as follows:

  • Average Manufacturer Price (AMP): Determine the AMP for the smallest unit of measure of the drug.
  • Unit Rebate Amount (URA): Calculate the URA based on the rebate agreement.
  • 340B Ceiling Price: Subtract the URA from the AMP to get the 340B ceiling price[5].

Key Takeaways

  • NDC Importance: Accurate use of NDCs is crucial for billing, reimbursement, and drug cost management.
  • Market Segmentation: The pharmaceutical market is segmented by price, with different segments having different growth projections.
  • Pricing Formulas: Prices for covered outpatient drugs are calculated using specific formulas, such as the 340B ceiling price.
  • Market Analysis: Detailed market analysis requires identifying the drug, analyzing historical sales data, assessing market drivers and constraints, and forecasting future sales.

FAQs

What is an NDC and why is it important?

An NDC is a unique 11-digit code assigned to each medication, crucial for accurate billing, reimbursement, and drug cost management.

How is the 340B ceiling price calculated?

The 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure of the drug.

What factors influence the pricing of prescription drugs?

Pricing is influenced by demographic trends, technological advancements, legal and regulatory changes, and market competition.

How do market segmentation and pricing structures affect drug sales?

Different market segments (cash, insurer/PBM, Medicaid) have different growth projections and pricing structures, which significantly impact drug sales.

Where can I find historical sales data for a specific drug?

Historical sales data can be obtained from market research reports, pharmaceutical company financial statements, or industry databases.

Sources

  1. Medicaid.gov - For State Medicaid Directors: State Releases
  2. BCBSIL - Billing with National Drug Codes (NDCs) Frequently Asked Questions
  3. BCC Research - Drug Markets by Price Tier: PHM033A
  4. CDC - IIS | Code Sets | NDC | Vaccines
  5. HRSA - NDC Product Details - Log into 340B OPAIS

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.